Role of bone marrow-derived cells in colon cancer: Lessons from mouse model studies

Journal of Gastroenterology

Volumn 44, Issue 2, 2009, Pages 93-102

  Taketo, Makoto Mark ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Adjuvant therapy; Bone marrow cells; Chemotherapy; Inflammation; Invasion; Metastasis; Progression; Tumor stroma

Indexed keywords

APC PROTEIN; BX 174; CHEMOKINE RECEPTOR ANTAGONIST; CHEMOKINE RECEPTOR CCR1; MATRIX METALLOPROTEINASE; SMAD4 PROTEIN; UNCLASSIFIED DRUG;

ADENOMATOUS POLYP; ADJUVANT THERAPY; BONE MARROW CELL; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER INVASION; CELL FUNCTION; CLINICAL TRIAL; COLON CANCER; COLON CARCINOGENESIS; DISEASE COURSE; DRUG MECHANISM; FAMILIAL DISEASE; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; IMMUNE RESPONSE; INFLAMMATION; MACROPHAGE; METASTASIS; MOLECULAR MECHANICS; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; STROMA; STROMA CELL;

ANIMALS; BONE MARROW CELLS; COLONIC NEOPLASMS; DISEASE MODELS, ANIMAL; HUMANS; MICE; MICE, MUTANT STRAINS; MYELOID CELLS; NEOPLASM INVASIVENESS; RECEPTORS, CHEMOKINE; STROMAL CELLS;

EID: 60449084008     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-008-2321-3     Document Type: Review

References (52)

1. Weinberg RA. Biology of cancer. New York: Garland Science; 2007. p. 25-56.
2. Joensuu H. Risk stratification of patients diagnosed with gastrointestinal stromal tumor. Hum Pathol 2008;39:1411-99.
3. Balkwill F, Mantovani A. Inflammation and cancer: Back to Virchow? Lancet 2001;357:539-45.
4. Wang TC, Fox JG. Helicobacter pylori and gastric cancer: Koch's postulates fulfilled? Gastroenterology 1998;115:780-3.
5. Rescigno M. The pathogenic role of intestinal flora in IBD and colon cancer. Curr Drug Targets 2008;9:395-403.
6. Moser AR, Pitot HC, Dove WF. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 1990;247:322-4.
7. Fodde R, Edelmann W, Yang K, van Leeuwen C, Carlson C, Renault B, et al. A targeted chain-termination mutation in the mouse Apc gene results in multiple tumors. Proc Natl Acad Sci U S A 1994;91:8969-73.
8. Oshima M, Oshima H, Kitagawa K, Kobayashi M, Itakura C, Taketo M. Loss of Apc heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Apc gene. Proc Natl Acad Sci U S A 1995;92:4482-6.
9. Groden J, Thliveris A, Samowitz W, Carlson M, Gelbert L, Albertsen H, et al. Identification and characterization of the familial adenomatous polyposis coli gene. Cell 1991;66:589-600.
10. Kinzler KW, Nilbert MC, Su L-K, Vogelstein B, Bryan TM, Levy DB, et al. Identification of FAP locus genes from chromosome 5q21. Science 1991;253:661-5.
11. Taketo MM. Wnt signaling and gastrointestinal tumorigenesis in mouse models. Oncogene 2006;25:7522-30.
12. Bodmer WF, Bailey CJ, Bodmer J, Bussey HJR, Ellis A, Gorman P, et al. Localization of the gene for familial adenomatous polyposis on chromosome 5. Nature 1987;328:614-9.
13. Miyaki M, Seki M, Okamoto M, Yamanaka A, Maeda Y, Tanaka K, et al. Genetic changes and histopathological types in colorectal tumors from patients with familial adenomatous polyposis. Cancer Res 1990;50:7166-73.
14. Ichii S, Horii A, Nakatsuru S, Furuyama J, Utsunomiya J, Nakamura Y. Inactivation of both APC alleles in an early stage of colon adenomas in a patient with familial adenomatous polyposis (FAP). Hum Mol Genet 1992;1:387-90.
15. Haigis KM, Dove WF. A Robertsonian translocation suppresses a somatic recombination pathway to loss of heterozygosity. Nat Genet 2003;33:33-9.
16. Takaku K, Oshima M, Miyoshi H, Matsui M, Seldin MF, Taketo MM. Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Apc genes. Cell 1998;92:645-56.
17. Kitamura T, Kometani K, Hashida H, Matsunaga A, Miyoshi H, Hosogi H, et al. SMAD4-deficient intestinal tumors recruit CCR1 + myeloid cells that promote invasion. Nat Genet 2007;39:467-75.
18. Δ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 1996;87:803-9.
19. Chulada PC, Thompson MB, Mahler JF, Doyle CM, Gaul BW, Lee C, et al. Genetic disruption of Ptgs-1, as well as of Ptgs-2, reduces intestinal tumorigenesis in Min mice. Cancer Res 2000;60:4705-8.
20. Biswas S, Chytil A, Washington K, Romero-Gallo J, Gorska AE, Wirth PS, et al. Transforming growth factor β receptor type II inactivation promotes the establishment and progression of colon cancer. Cancer Res 2004;64:4687-92.
21. Lin X, Chen Y-G, Feng X-H. Transcriptional control via Smads. In: Derynck R, editor. The TGF-β family. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press; 2008. p. 287-332.
22. Oshima M, Oshima H, Taketo MM. TGF-β receptor type II deficiency results in defects of yolk sac hematopoiesis and vasculogenesis. Dev Biol 1996;179:297-302.
23. Takaku K, Miyoshi H, Matsunaga A, Oshima M, Sasaki N, Taketo MM. Gastric and duodenal polyps in Smad4 (Dpc4) knockout mice. Cancer Res 1999;59:6113-7.
24. Condeelis J, Pollard JW. Macrophages: Obligate partners for tumor cell migration, invasion, and metastasis. Cell 2006;124:263-6.
25. Direkze NC, Hodivala-Dilke K, Jeffery R, Hunt T, Poulsom R, Oukrif D, et al. Bone marrow contribution to tumor-associated myofibroblasts and fibroblasts. Cancer Res 2004;64:8492-5.
26. Garmy-Susini B, Varner JA. Circulating endothelial progenitor cells. Br J Cancer 2005;93:855-8.
27. Lewis CE, Pollard JW. Distinct role of macrophages in different tumor microenvironments. Cancer Res 2006;66:605-12.
28. Mook ORF, van Overbeek C, Ackema EG, van Maldegem F, Fredericks WM. In situ localization of gelatinolytic activity in the extracellular matrix of metastasis of colon cancer in rat liver using quenched fluoregenic DQ-gelatin. J Histochem Cytochem 2003;51:821-9.
29. Miyaki M, Iijima T, Konishi M, Sakai K, Ishii A, Yasuno M, et al. Higher frequency of Smad4 gene mutation in human colorectal cancer with distant metastasis. Oncogene 1999;18:3098-103.
30. Markowitz S. TGF-β receptors and DNA repair genes, coupled targets in a pathway of human colon carcinogenesis. Biochim Biophys Acta 2000;1470:M13-20.
31. Coussens LM, Fingleton B, Matrisian LM. Matrix metalloproteinase inhibitors and cancer: Trials and tribulations. Science 2002;295:2387-92.
32. Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002;2:161-74.
33. Overall CM, Kleifeld O. Validating matrix metallo-proteinases as drug targets and anti-targets for cancer therapy. Nat Rev Cancer 2006;6:227-39.
34. Kitamura T, Taketo MM. Keeping out the bad guys: Gateway to cellular target therapy. Cancer Res 2007;67:10099-102.
35. Horuk R. BX471: A CCR1 antagonist with anti-inflammatory activity in man. Mini Rev Med Chem 2005;5:791-804.
36. Powell DW, Adegboyega PA, Di Mari JF, Mifflin RC. Epithelial cells and their neighbors. I. Role of intestinal myofibroblasts in development, repair, and cancer. Am J Phys Gastrointest Liver Physiol 2005;289:G2-7.
37. Varro A. Stromal cells and tumor microenvironment. In: Wang T, editor. Biology of gastric cancers. New York: Springer; 2008. p. 587-601.
38. Jodele S, Blavier L, Yoon JM, DeClerck YA. Modifying the soil to affect the seed: Role of stromal-derived matrix metalloproteinases in cancer progression. Cancer Metastasis Rev 2006;25:35-43.
39. Sonoshita M, Takaku K, Oshima M, Sugihara K, Taketo MM. Cyclooxygenase-2 expression in fibroblasts and endothelial cells of intestinal polyps. Cancer Res 2002;62:6846-9.
40. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100:57-70.
41. Kaplan RN, Riba RD, Zacharoulis S, Bramley AH, Vincent L, Costa C, et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 2005;438:820-7.
42. Lin EY, Nguyen AV, Russel RG, Pollard JW. Colonystimulating factor 1 promotes progression of mammary tumors to malignancy. J Exp Med 2001;193:727-39.
43. Lin EY, Li J-F, Bricard G, Wang W, Deng Y, Sellers R, et al. Vascular endothelial growth factor restores delayed tumor progression in tumors depleted of macrophages. Mol Oncol 2007;1:288-302.
44. Goswami S, Sahai E, Wyckoff JB, Cammer M, Cox D, Pixley FJ, et al. Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1/epidermal growth factor paracrine loop. Cancer Res 2005;65:5278-83.
45. Wyckoff JB, Wang Y, Lyn EY, Li JF, Goswami S, Stanley ER, et al. Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors. Cancer Res 2007;67:2629-56.
46. Oguma K, Oshima H, Aoki M, Uchio R, Naka K, Nakamura S, et al. Activated macrophages promote Wnt signalling through necrosis factor-α in gastric tumor cells. EMBO J 2008;27:1671-81.
47. Biswas SK, Gangi L, Paul S, Schioppa T, Saccani A, Sironi M, et al. A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-κ B and enhanced IRF-3/ STAT1 activation). Blood 2006;107:2112-22.
48. Watkins SK, Egilmez NK, Suttles J, Strout RD. IL-12 rapidly alters the functional profile of tumor-associated and tumorinfiltrating macrophages in vitro and in vivo. J Immunol 2007;2007:1357-62.
49. Yang L, Huang J, Ren X, Gorska AE, Chytil A, Aakre M, et al. Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis. Cancer Cell 2008;13:23-35.
50. Karnoub AE, Dash AB, Vo AP, Sullivan A, Brooks MW, Bell GW, et al. Mesencyomal stem cells within tumor stroma promote breast cancer metastasis. Nature 2007;449:557-63.
51. Houghton J, Stoicov C, Nomura S, Rogers AB, Carlson J, Li H, et al. Gastric cancer originating from bone marrow-derived cells. Science 2004;306:1568-71.
52. Houghton J, Wang TC. Role of bone marrow-derived cells in gastric adenocarcinoma. In: Wang T, editor. Biology of gastric cancers. New York: Springer; 2008. p. 561-86.